The Functional Neuroanatomy of the Placebo Effect
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Administration of placebo can result in a clinical response indistinguishable from that seen with active antidepressant treatment. Functional brain correlates of this phenomenon have not been fully characterized. METHOD: Changes in brain glucose metabolism were measured by using positron emission tomography in hospitalized men with unipolar depression who were administered placebo as part of an inpatient imaging study of fluoxetine. Common and unique response effects to administration of placebo or fluoxetine were assessed after a 6-week, double-blind trial. RESULTS: Placebo response was associated with regional metabolic increases involving the prefrontal, anterior cingulate, premotor, parietal, posterior insula, and posterior cingulate and metabolic decreases involving the subgenual cingulate, parahippocampus, and thalamus. Regions of change overlapped those seen in responders administered active fluoxetine. Fluoxetine response, however, was associated with additional subcortical and limbic changes in the brainstem, striatum, anterior insula, and hippocampus, sources of efferent input to the response-specific regions identified with both agents. CONCLUSIONS: The common pattern of cortical glucose metabolism increases and limbic-paralimbic metabolism decreases in placebo and fluoxetine responders suggests that facilitation of these changes may be necessary for depression remission, regardless of treatment modality. Clinical improvement in the group receiving placebo as part of an inpatient study is consistent with the well-recognized effect that altering the therapeutic environment may significantly contribute to reducing clinical symptoms. The additional subcortical and limbic metabolism decreases seen uniquely in fluoxetine responders may convey additional advantage in maintaining long-term clinical response and in relapse prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
Talairach, J., Tournoux, P., & Rayport, M. (1988) · Thieme eBooks · Cited by 5,058
Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,418
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Self-citationElkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
A three-dimensional statistical analysis for CBF activation studies in human brain
Worsley, K. J., Evans, A. C., Marrett, S., & Neelin, P. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.127 · Cited by 2,036
A Suggestion for Using Powerful and Informative Tests of Normality
D'agostino, R. B., Belanger, A., & D'agostino, R. B. (1990) · The American Statistician · doi:10.2307/2684359 · Cited by 1,809
A Suggestion for Using Powerful and Informative Tests of Normality
D'agostino, R. B., Belanger, A., & D'agostino, R. B. (1990) · The American Statistician · doi:10.1080/00031305.1990.10475751 · Cited by 1,804
Research works printed but not linked: 1
- Schwartz JM: A role for volition and attention in the generation of new brain circuits. J Consciousness Studies 1999; 6:115-142
Cited by
Greicius, M. D., Flores, B. H., Menon, V., Glover, G. H., Solvason, H. B., Kenna, H., Reiss, A. L., & Schatzberg, A. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.020 · Cited by 2,214
Hippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Mayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166
Self-citationA Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
Price, D. D., Finniss, D. G., & Benedetti, F. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.113006.095941 · Cited by 1,146
“In another study, changes in brain glucose metabolism were measured by using positron emission tomography in subjects with unipolar depression (Mayberg et al. 2002).”
Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., & Mayberg, H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.34 · Cited by 1,068
Self-citationThe neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response
Pizzagalli, D. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.166 · Cited by 945
A meta‐analytic study of changes in brain activation in depression
Fitzgerald, P. B., Laird, A. R., Maller, J., & Daskalakis, Z. J. (2008) · Human Brain Mapping · doi:10.1002/hbm.20426 · Cited by 903
The role of the hippocampus in the pathophysiology of major depression
Campbell, S., & MacQueen, G. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0441 · Cited by 880
The neuroscience of placebo effects: connecting context, learning and health
Wager, T. D., & Atlas, L. Y. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3976 · Cited by 844
Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04315.2003 · Cited by 788
“…of psychological factors on several body functions such as pain (Amanzio and Benedetti, 1999; Benedetti et al., 1999b; Petrovic et al., 2002; Pollo et al., 2003), motor performance (de la Fuente- Fernandez et al., 2001; Pollo et al., 2002), and mood (Leuchter et al., 2002; Mayberg et al., 2002).”
BackgroundInfluentialNeurobiological Mechanisms of the Placebo Effect
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3458-05.2005 · Cited by 777
Self-citationCellular changes in the postmortem hippocampus in major depression
Stockmeier, C. A., Mahajan, G. J., Konick, L. C., Overholser, J. C., Jurjus, G. J., Meltzer, H. Y., Uylings, H. B. M., Friedman, L., & Rajkowska, G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.022 · Cited by 732
“Other evidence of dissimilarities between prefrontal cortex and hippocampus in depression comes from the work of Mayberg and colleagues (Kennedy et al 2001; Mayberg et al 2000, 2002).”
MethodPosttraumatic stress disorder: a state-of-the-science review
Nemeroff, C. B., Bremner, J. D., Foa, E. B., Mayberg, H. S., North, C. S., & Stein, M. B. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.005 · Cited by 675
Self-citationThe placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671
Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.34 · Cited by 637
When words are painful: unraveling the mechanisms of the nocebo effect
Benedetti, F., Lanotte, M., Lopiano, L., & Colloca, L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.020 · Cited by 636
“There is also some experimental evidence that different serotonin-related brain regions are involved in the placebo response in depression (Leuchter et al., 2002; Mayberg et al., 2002; Benedetti et al., 2005).”
BackgroundGetting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans
Tracey, I. (2010) · Nature Medicine · doi:10.1038/nm.2229 · Cited by 553
“, and subsequent PET and fMRI work in a range of disorders confirmed that the NAc is involved in placebo effect”
BackgroundLinde, K., Witt, C. M., Streng, A., Weidenhammer, W., Wagenpfeil, S., Brinkhaus, B., Willich, S. N., & Melchart, D. (2007) · Pain · doi:10.1016/j.pain.2006.12.006 · Cited by 551
Targeted electrode-based modulation of neural circuits for depression.
Mayberg, H. S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38454 · Cited by 542
Self-citationThe neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
“Similar changes were also seen n depressed patients who responded to placebo treatment, though uoxetine and placebo had different effects in other brain regions Mayberg et al., 2002).”
ResultThe subcallosal cingulate gyrus in the context of major depression
Hamani, C., Mayberg, H., Stone, S., Laxton, A., Haber, S., & Lozano, A. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.034 · Cited by 508
Self-citationHow psychotherapy changes the brain – the contribution of functional neuroimaging
Linden, D. E. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001816 · Cited by 491
Placebo and the New Physiology of the Doctor-Patient Relationship
Benedetti, F. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2012 · Cited by 492
“In a different study (229), changes in brain glucose metabolism were measured by means of positron emission tomography in unipolar depression patients who received either a placebo or fluoxetine for 6 wk, and common and unique responses were described.”
BackgroundMethodPlacebos and painkillers: is mind as real as matter?
Colloca, L., & Benedetti, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1705 · Cited by 465
How Placebos Change the Patient's Brain
Benedetti, F., Carlino, E., & Pollo, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.81 · Cited by 446
“Moreover, such changes could not be observed in either the eventual drug nonresponders at 1 week or in drug responders at 6 weeks, when the antidepressant response was well established, consistent with an expectation pattern of response (Mayberg et al, 2002; Benedetti et al, 2005).”
BackgroundHow prior experience shapes placebo analgesia
Colloca, L., & Benedetti, F. (2006) · Pain · doi:10.1016/j.pain.2006.04.005 · Cited by 443
Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments
Benedetti, F. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094711 · Cited by 385
Effects of electroacupuncture versus manual acupuncture on the human brain as measured by fMRI
Napadow, V., Makris, N., Liu, J., Kettner, N. W., Kwong, K. K., & Hui, K. K. S. (2005) · Human Brain Mapping · doi:10.1002/hbm.20081 · Cited by 376
Jakobsen, J. C., Katakam, K. K., Schou, A., Hellmuth, S. G., Stallknecht, S. E., Leth-Møller, K., Iversen, M., Banke, M. B., Petersen, I. J., Klingenberg, S. L., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1173-2 · Cited by 366
Brain–gut connections in functional GI disorders: Anatomic and physiologic relationships
Jones, M. P., Dilley, J. B., Drossman, D., & Crowell, M. D. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00730.x · Cited by 358
Lozano, A. M., Giacobbe, P., Hamani, C., Rizvi, S. J., Kennedy, S. H., Kolivakis, T. T., Debonnel, G., Sadikot, A. F., Lam, R. W., Howard, A. K., et al. (2012) · Journal of Neurosurgery · doi:10.3171/2011.10.jns102122 · Cited by 356
Self-citationWhat catatonia can tell us about “top-down modulation”: A neuropsychiatric hypothesis
Northoff, G. (2002) · Behavioral and Brain Sciences · doi:10.1017/s0140525x02000109 · Cited by 350
Benedetti, F., Arduino, C., Costa, S., Vighetti, S., Tarenzi, L., Rainero, I., & Asteggiano, G. (2006) · Pain · doi:10.1016/j.pain.2005.12.016 · Cited by 347
Meta-analysis of the placebo response in antidepressant trials.
Rief, W., Nestoriuc, Y., Weiss, S., Welzel, E., Barsky, A. J., & Hofmann, S. G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.029 · Cited by 346
“However, other studies have found thatmany predictors and correlates of change are similar between placebo and antidepressant drug responders (Leuchter et al., 2002; Mayberg et al., 2002); this notion is confirmed by the high correlation of placebo group effect sizes and drug group effect sizes in our analysis (r=0.”
ResultLiotti, M., Mayberg, H. S., McGinnis, S., Brannan, S. L., & Jerabek, P. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1830 · Cited by 331
Self-citationDecreased Regional Brain Metabolism After ECT
Nobler, M. S., Oquendo, M. A., Kegeles, L. S., Malone, K. M., Campbell, C., Sackeim, H. A., & Mann, J. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.305 · Cited by 330
Schedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009423 · Cited by 323
“In patients with social anxiety, connectivity changes between the amygdala and dorsolateral prefrontal cortex and rACC areas have been shown to be associated with the individual anxiolytic response to SSRI treatment and placebo, as demonstrated in PET.”
MethodInfluentialEffects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
Lidstone, S. C., Schulzer, M., Dinelle, K., Mak, E., Sossi, V., Ruth, T. J., de la Fuente-Fernández, R., Phillips, A. G., & Stoessl, A. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.88 · Cited by 323
Feeling the Pain of Social Loss
Panksepp, J. (2003) · Science · doi:10.1126/science.1091062 · Cited by 318
Harshaw, C. (2015) · Psychological Bulletin · doi:10.1037/a0038101 · Cited by 302
“…using fMRI or PET, finding both that SSRIs result in decreased insula activation (e.g., Arce et al., 2008; Kennedy et al., 2001; Kraus et al., 2014; Mayberg et al., 2002, 2009; Simmons et al., 2009) and that changes in insula activity (in addition to decreases in sgACC and hippocampus, and…”
BackgroundWampold, B. E., Minami, T., Tierney, S. C., Baskin, T. W., & Bhati, K. S. (2005) · Journal of Clinical Psychology · doi:10.1002/jclp.20129 · Cited by 298
Bluhm, R., Williamson, P., Lanius, R., Théberge, J., Densmore, M., Bartha, R., Neufeld, R., & Osuch, E. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02030.x · Cited by 294
The neural correlates of placebo effects: a disruption account
Lieberman, M. D., Jarcho, J. M., Berman, S., Naliboff, B. D., Suyenobu, B. Y., Mandelkern, M., & Mayer, E. A. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.01.037 · Cited by 289
Neurobiological Mechanisms of Placebo Responses
Zubieta, J., & Stohler, C. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04424.x · Cited by 277
A Model of Placebo Response in Antidepressant Clinical Trials
Rutherford, B. R., & Roose, S. P. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040474 · Cited by 268
Phillips, M. L., Chase, H. W., Sheline, Y. I., Etkin, A., Almeida, J. R. C., Deckersbach, T., & Trivedi, M. H. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010076 · Cited by 267
Genetics and the placebo effect: the placebome
Hall, K. T., Loscalzo, J., & Kaptchuk, T. J. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.02.009 · Cited by 266
Positron emission tomography imaging in depression: a neural systems perspective
Mayberg, H. S. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00104-7 · Cited by 255
Self-citationGoetz, C. G., Wuu, J., McDermott, M. P., Adler, C. H., Fahn, S., Freed, C. R., Hauser, R. A., Olanow, W. C., Shoulson, I., Tandon, P. K., et al. (2008) · Movement Disorders · doi:10.1002/mds.21894 · Cited by 253
Beauregard, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.005 · Cited by 251
“As for MDD, placebo can produce metabolic changes in cortical and paralimbic brain regions that are relatively similar to those of fluoxetine (Mayberg et al., 2002).”
BackgroundMethodHow can drug discovery for psychiatric disorders be improved?
Agid, Y., Buzsáki, G., Diamond, D. M., Frackowiak, R., Giedd, J., Girault, J.-A., Grace, A., Lambert, J. J., Manji, H., Mayberg, H., et al. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2217 · Cited by 240
Self-citationPlacebo effects: clinical aspects and neurobiology
Oken, B. S. (2008) · Brain · doi:10.1093/brain/awn116 · Cited by 237
“, 2002) and improvements in mood associated with administration of placebo (Mayberg et al., 2002).”
BackgroundInfluentialInterventions for generalized anxiety disorder in older adults: Systematic review and meta-analysis
Gonçalves, D. C., & Byrne, G. J. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.08.010 · Cited by 227
Furmark, T., Appel, L., Henningsson, S., Åhs, F., Faria, V., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2534-08.2008 · Cited by 210
“The present results are consistent with the notion that placebo and active pharmacological agents act on the same, or at least overlapping, neural pathways (Mayberg et al., 2002; Petrovic et al., 2002, 2005; Benedetti et al., 2005; Faria et al., 2008).”
ResultYao, Z., Wang, L., Lu, Q., Liu, H., & Teng, G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.013 · Cited by 205
Altering expectancy dampens neural response to aversive taste in primary taste cortex
Nitschke, J. B., Dixon, G. E., Sarinopoulos, I., Short, S. J., Cohen, J. D., Smith, E. E., Kosslyn, S. M., Rose, R. M., & Davidson, R. J. (2006) · Nature Neuroscience · doi:10.1038/nn1645 · Cited by 199
Dougherty, D. D., Weiss, A. P., Cosgrove, G. R., Alpert, N. M., Cassem, E. H., Nierenberg, A. A., Price, B. H., Mayberg, H. S., Fischman, A. J., & Rauch, S. L. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.6.1010 · Cited by 193
Self-citationBrain Mechanisms of the Placebo Effect: An Affective Appraisal Account
Ashar, Y. K., Chang, L. J., & Wager, T. D. (2017) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-021815-093015 · Cited by 191
Serotonin alterations in anorexia and bulimia nervosa: New insights from imaging studies
KAYE, W., FRANK, G., BAILER, U., HENRY, S., MELTZER, C., PRICE, J., MATHIS, C., & WAGNER, A. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.04.013 · Cited by 181
Guo, W.-B., Liu, F., Xue, Z.-M., Xu, X.-J., Wu, R.-R., Ma, C.-Q., Wooderson, S. C., Tan, C.-L., Sun, X.-L., Chen, J.-D., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.011 · Cited by 181
“ACC plays a critical role in the cognition and emotional regulation (MacDonald et al., 2000; Mayberg et al., 2002).”
BackgroundBailer, U. F., Frank, G. K., Henry, S. E., Price, J. C., Meltzer, C. C., Weissfeld, L., Mathis, C. A., Drevets, W. C., Wagner, A., Hoge, J., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.1032 · Cited by 182
How the doctor's words affect the patient's brain
Benedetti, F. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702238051 · Cited by 173
“Placebo response was associated with metabolic increases in the prefrontal, anterior cingulate, premotor, parietal, posterior insula, and posterior cingulate and metabolic decreases in the subgenual cingulate, para-hippocampus, and thalamus (Mayberg et al., 2002).”
BackgroundEvans, J. W., Szczepanik, J., Brutsché, N., Park, L. T., Nugent, A. C., & Zarate, C. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.027 · Cited by 173
Kemp, A. H., Gordon, E., Rush, A. J., & Williams, L. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900017120 · Cited by 170
Role of expectations in health
Colloca, L., & Miller, F. G. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328343803b · Cited by 161
The placebo response: how words and rituals change the patient's brain
Benedetti, F., & Amanzio, M. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.04.034 · Cited by 132
“By using PET, changes in brain glucose metabolism have also been documented in subjects with unipolar depression [37].”
MethodExpectation of caffeine induces dopaminergic responses in humans
Kaasinen, V., Aalto, S., Någren, K., & Rinne, J. O. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03310.x · Cited by 118
Zobel, A., Joe, A., Freymann, N., Clusmann, H., Schramm, J., Reinhardt, M., Biersack, H.-J., Maier, W., & Broich, K. (2005) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2005.02.010 · Cited by 117
The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review
Demyttenaere, K., & Van Duppen, Z. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy052 · Cited by 98
The placebo response in functional bowel disorders: perspectives and putative mechanisms
Enck, P., & Klosterhalfen, S. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00676.x · Cited by 101
Expectancy in placebo-controlled trials of psychedelics: if so, so what?
Butler, M., Jelen, L., & Rucker, J. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06221-6 · Cited by 100
The placebo-reward hypothesis: dopamine and the placebo effect
de la Fuente-Fernández, R. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70785-0 · Cited by 95
Functional neuroimaging in specific phobia
Del Casale, A., Ferracuti, S., Rapinesi, C., Serata, D., Piccirilli, M., Savoja, V., Kotzalidis, G. D., Manfredi, G., Angeletti, G., Tatarelli, R., et al. (2012) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2011.10.009 · Cited by 90
“non-responder groups in SP, as described previously for depression (Mayberg et al., 2002) and obsessive–compulsive disorder (Yamanishi et al.”
BackgroundAre Mental Illnesses Diseases of the Brain?
Fuchs, T. (2011) · Critical Neuroscience · doi:10.1002/9781444343359.ch16 · Cited by 86
Salience Network Functional Connectivity Predicts Placebo Effects in Major Depression
Sikora, M., Heffernan, J., Avery, E. T., Mickey, B. J., Zubieta, J.-K., & Peciña, M. (2016) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.10.002 · Cited by 85
“Our data, to our knowledge, are also the first demonstration of SN involvement in MDD placebo effects and thus, supplement the small existing body of work in the neurobiology of placebo in patients with MDD (15, 61).”
BackgroundResultTwo-week delay in onset of action of antidepressants: new evidence
Mitchell, A. J. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.011692 · Cited by 82
Aging and alexithymia association with reduced right rostral cingulate volume
Paradiso, S., Vaidya, J. G., McCormick, L. M., Jones, A., & Robinson, R. G. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31817e73b0 · Cited by 80
“Broadly speaking, functional imaging and lesion studies have suggested that dorsal aspects of the ACC subserve motor, attention and cognitive functions,(55) whereas more ventral aspects (rostral, and subgenual regions) are involved with emotions and autonomic functions.(56,57) We therefore hypothesized that subregions…”
BackgroundPardo, J. V., Sheikh, S. A., Schwindt, G. C., Lee, J. T., Kuskowski, M. A., Surerus, C., Lewis, S. M., Abuzzahab, F. S., Adson, D. E., & Rittberg, B. R. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.267 · Cited by 79
Chen, M.-H., Lin, W.-C., Tu, P.-C., Li, C.-T., Bai, Y.-M., Tsai, S.-J., & Su, T.-P. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.08.022 · Cited by 78
Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder
Faria, V., Appel, L., Åhs, F., Linnman, C., Pissiota, A., Frans, Ö., Bani, M., Bettica, P., Pich, E. M., Jacobsson, E., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.72 · Cited by 73
Bartlett, E. A., DeLorenzo, C., Sharma, P., Yang, J., Zhang, M., Petkova, E., Weissman, M., McGrath, P. J., Fava, M., Ogden, R. T., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0122-9 · Cited by 72
Wagner, S., Engel, A., Engelmann, J., Herzog, D., Dreimüller, N., Müller, M. B., Tadić, A., & Lieb, K. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.003 · Cited by 73
Faria, V., Gingnell, M., Hoppe, J. M., Hjorth, O., Alaie, I., Frick, A., Hultberg, S., Wahlstedt, K., Engman, J., Månsson, K. N. T., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.031 · Cited by 70
Evans, K. C., Simon, N. M., Dougherty, D. D., Hoge, E. A., Worthington, J. J., Chow, C., Kaufman, R. E., Gold, A. L., Fischman, A. J., Pollack, M. H., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.69 · Cited by 68
“09, cluster threshold 15 voxels). gSAD, generalized social anxiety disorder (entire pretreatment cohort, N¼ 15); gSAD-NR, treatment nonresponder (N¼ 5); gSAD-R, treatment responder (N¼ 7); HC, healthy control (N¼ 10); dACC, dorsal anterior cingulate cortex; SC, subcallosal cortex.”
InfluentialChanges in regional cerebral blood flow following antidepressant treatment in late‐life depression
Ishizaki, J., Yamamoto, H., Takahashi, T., Takeda, M., Yano, M., & Mimura, M. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1980 · Cited by 68
Cellular abnormalities in depression: evidence from postmortem brain tissue
Stockmeier, C. A., & Rajkowska, G. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.2/cstockmeier · Cited by 67
Rief, W., Barsky, A. J., Bingel, U., Doering, B. K., Schwarting, R., Wöhr, M., & Schweiger, U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.008 · Cited by 67
Disgust regulation via placebo: an fMRI study
Schienle, A., Übel, S., Schöngaßner, F., Ille, R., & Scharmüller, W. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst072 · Cited by 61
“The influence of a placebo on emotional processing has hardly been investigated (Mayberg et al., 2002; Petrovic et al., 2005).”
BackgroundAn, J., Wang, L., Li, K., Zeng, Y., Su, Y., Jin, Z., Yu, X., & Si, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-10575-9 · Cited by 48
Cerrillo-Urbina, A. J., García-Hermoso, A., Pardo-Guijarro, M. J., Sánchez-López, M., Santos-Gómez, J. L., & Martínez-Vizcaíno, V. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0151 · Cited by 44
“neurochemical and neurophysiological changes (Mayberg et al. 2002), in such a way that participation in clinical research may itself be therapeutic (Horwitz and Horwitz 1993).”
Herbert, J. D., & Gaudiano, B. A. (2005) · Journal of Clinical Psychology · doi:10.1002/jclp.20133 · Cited by 44
Smith, G. S., Kahn, A., Sacher, J., Rusjan, P., van Eimeren, T., Flint, A., & Wilson, A. A. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318227f83f · Cited by 32
“The second issue is the lack of a placebo control group, as changes in cerebral glucose metabolism similar to those observed with antidepressant treatment have been observed in placebo treated patients in pharmacologic treatment studies (36).”
ResultFountoulakis, K. N., & Möller, H.-J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111421969 · Cited by 30
“, 2001), while others suggest that the neurochemistry behind the drug response and the response in the placebo group are different (Mayberg et al., 2002).”
BackgroundNeural mechanisms of expectancy-based placebo effects in antidepressant clinical trials
Zilcha-Mano, S., Wang, Z., Peterson, B. S., Wall, M. M., Chen, Y., Wager, T. D., Brown, P. J., Roose, S. P., & Rutherford, B. R. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.05.023 · Cited by 21
Nishida, M., Kikuchi, S., Nisijima, K., & Suda, S. (2017) · The Journal of ECT · doi:10.1097/yct.0000000000000352 · Cited by 19
(2020) · Advances in Pharmacology · doi:10.1016/bs.apha.2020.04.003 · Cited by 18
Classical conditioning of antidepressant placebo effects in mice
Krimmel, S. R., Zanos, P., Georgiou, P., Colloca, L., & Gould, T. D. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05347-4 · Cited by 12
Ang, Y.-S., Bruder, G. E., Keilp, J. G., Rutherford, A., Alschuler, D. M., Pechtel, P., Webb, C. A., Carmody, T., Fava, M., Cusin, C., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291720004286 · Cited by 12
“High placebo responses are commonly reported in clinical trials of novel antidepressants (Enck, Bingel, Schedlowski, & Rief, 2013; Schatzberg, 2015) and treatment with placebo has been found to induce distinct changes in brain functioning of depressed individuals (Enck et al., 2013; Leuchter, Cook, Witte, Morgan, & Ab…”
Background
Metadata
- Authors
- Mayberg, H. S., Silva, J. A., Brannan, S. K., Tekell, J. L., Mahurin, R. K., McGinnis, S., & Jerabek, P. A.
- Venue
- American Journal of Psychiatry
- Published
- 2002-05-01
- Volume
- 159
- Issue
- 5
- Pages
- 728-737
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2135842063
- Cited by
- 720
- References
- 90
- FWCI
- 21.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.